Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 3

Results For "specialty-pharmaceutical"

36 News Found

Ajanta Pharma bags India’s
News | October 18, 2022

Ajanta Pharma bags India’s "Best Managed Companies" award

For the last ten financial years, the company has posted healthy performance with its revenue from operations growing at 15% CAGR and net profit at 23% CAGR


ANDA approval from USFDA for Unichem's Extended Phenytoin Sodium Capsules
Drug Approval | October 15, 2022

ANDA approval from USFDA for Unichem's Extended Phenytoin Sodium Capsules

Extended Phenytoin Sodium Capsules are indicated for the treatment of tonic-clonic (grand mal) and psychomotor (temporal lobe) seizures


Unichem Laboratories receives ANDA approval for Carbamazepine Tablets
Drug Approval | August 24, 2022

Unichem Laboratories receives ANDA approval for Carbamazepine Tablets

Carbamazepine Tablets are indicated for use as an anticonvulsant drug and in the treatment of the pain associated with true trigeminal neuralgia


China Pharma submits plan of compliance to NYSE American
News | July 18, 2022

China Pharma submits plan of compliance to NYSE American

The company was directed to submit a plan of compliance by July 15, 2022


UPS Healthcare revolutionizes prioritized shipping with UPS Premier
Supply Chain | July 16, 2022

UPS Healthcare revolutionizes prioritized shipping with UPS Premier

Upgrades and global expansion provide additional control, visibility, reliability and recovery for patient-critical, time-and temperature-sensitive products


Prolacta Bioscience appoints David Steinberg as CFO
People | June 08, 2022

Prolacta Bioscience appoints David Steinberg as CFO

Steinberg brings nearly three decades of experience in biopharmaceutical equity research to Prolacta's executive team.


MEI Pharma and Kyowa Kirin report new clinical data on Zandelisib
News | June 07, 2022

MEI Pharma and Kyowa Kirin report new clinical data on Zandelisib

he Phase 2 TIDAL data generated to date continue to highlight zandelisib's therapeutic profile and the potential to benefit patients


Lonza signs manufacturing agreement with Oasmia Pharmaceutical
News | March 21, 2022

Lonza signs manufacturing agreement with Oasmia Pharmaceutical

Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply


Azurity Pharma gets USFDA approval for Fleqsuvy
Drug Approval | February 08, 2022

Azurity Pharma gets USFDA approval for Fleqsuvy

Nearly 1 million people are living with multiple sclerosis in the United States. Spasticity is a commonly reported symptom for MS, with an estimated prevalence of spasticity of 67%


Cosette Pharma acquires rights to Daiichi Sankyo’s eight branded products
Biotech | January 18, 2022

Cosette Pharma acquires rights to Daiichi Sankyo’s eight branded products

As part of Daiichi Sankyo’s 2030 vision, it plans to strengthen its oncology portfolio